U.S. chemical giant FMC (NYSE:FMC) and Europe-based Belchim Crop Protection have reached an agreement whereby FMC will acquire the rights to develop, register, manufacture, and market valifenalate, a fungicide used in the protection of "high-value" crops including grapes and tomatoes, FMC announced today. Valifenalate is currently being marketed under the name Valis.
The deal for valifenalate gives FMC the rights to market the patented fungicide to markets in North America, Latin America, and "some select countries outside of the Americas," according to FMC's statement.
FMC agricultural solutions president Mark Douglas commented in the company press release, "With targeted acquisitions like this one, FMC continues to diversify its crop protection portfolio in a manner that delivers more value to growers."
FMC will begin selling valifenalate in Latin America immediately, with plans to roll the product out to additional markets "soon after." Financial terms of the deal were not disclosed.
Fool contributor Tim Brugger has no position in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
More from The Motley Fool
Lithium Was Just One of the Factors That Drove FMC Stock Up 67.4% in 2017
Here's why FMC shares surged despite a lackluster operational performance.
3 Lithium Stocks to Buy for 2018
These unique catalysts ensure that the world's three largest lithium miners are still good bets in the year ahead -- and beyond.
FMC (FMC) Q3 2017 Earnings Conference Call Transcript
FMC earnings call for the period ending September 30, 2017.